alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<RESTATED> 
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       1,445,798
<SECURITIES>                                41,202,123
<RECEIVABLES>                               73,051,874
<ALLOWANCES>                                 7,853,350
<INVENTORY>                                  4,388,290
<CURRENT-ASSETS>                           120,916,840
<PP&E>                                      59,269,260
<DEPRECIATION>                              19,691,015
<TOTAL-ASSETS>                             293,947,527
<CURRENT-LIABILITIES>                       35,240,338
<BONDS>                                    125,000,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       244,303
<OTHER-SE>                                 127,889,201
<TOTAL-LIABILITY-AND-EQUITY>               293,947,527
<SALES>                                              0
<TOTAL-REVENUES>                           225,076,500
<CGS>                                                0
<TOTAL-COSTS>                              114,803,209
<OTHER-EXPENSES>                            76,376,801
<LOSS-PROVISION>                            10,240,920
<INTEREST-EXPENSE>                           6,364,556
<INCOME-PRETAX>                             17,291,270
<INCOME-TAX>                                 6,608,871
<INCOME-CONTINUING>                         10,682,399
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                10,682,399
<EPS-PRIMARY>                                      .44
<EPS-DILUTED>                                      .43
        

</TABLE>
Exhibit
32.2



CERTIFICATION
PURSUANT TO



SECTION
1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,



AS
ADOPTED PURSUANT TO



SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant
to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the
undersigned, as Chief Financial Officer of Silver Spike Investment Corp. (the “Company”), does hereby certify that to the
undersigned’s knowledge:



1)
the Company’s Form 10-K/A for the year ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) as applicable
of the Securities Exchange Act of 1934, as amended; and



2)
the information contained in the Company’s Form 10-K/A for the year ended March 31, 2022 fairly presents, in all material respects,
the financial condition and results of operations of the Company.



|Date: June 30,
    2022 |  | By: | /s/
    Gregory Gentile                                      
|----------------------- |  | --- | -------------------------------------------------------------
|                        |  |     | Gregory
    Gentile                                          
|                        |  |     | Chief
Financial Officer
    (Principal
    Financial Officer)
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. SS.1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with the Annual  Report of IR  BioSciences  Holdings,  Inc. (the
"Company")  on Form  10-QSB/A for the three months ended March 31, 2005 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
I, Michael Wilhelm, Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C.  ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:


1. The Report fully complies with the  requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. The  information  contained in the Report  fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.


                              /s/ Michael Wilhelm
                              -----------------------
                              Chief Executive Officer
                              November 16, 2005


A signed  original of this written  statement  required by Section 906, an other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
required by Section  906,  has been  provided to Company and will be retained by
the Company and furnished to the Securities and Exchange Commission or its staff
upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                                     <C>
<PERIOD-TYPE>                           6-MOS
<FISCAL-YEAR-END>                       APR-1-2000
<PERIOD-END>                            SEP-30-1999
<CASH>                                             10,018
<SECURITIES>                                       21,463
<RECEIVABLES>                                      14,201
<ALLOWANCES>                                        1,051
<INVENTORY>                                        13,161
<CURRENT-ASSETS>                                   60,960
<PP&E>                                             35,159
<DEPRECIATION>                                     20,708
<TOTAL-ASSETS>                                     78,838
<CURRENT-LIABILITIES>                              12,889
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                           21,337
<OTHER-SE>                                         44,612
<TOTAL-LIABILITY-AND-EQUITY>                       78,838
<SALES>                                            33,034
<TOTAL-REVENUES>                                   33,034
<CGS>                                              21,466
<TOTAL-COSTS>                                      29,127
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                      0
<INCOME-PRETAX>                                     4,558
<INCOME-TAX>                                        1,504
<INCOME-CONTINUING>                                 3,054
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                        3,054
<EPS-BASIC>                                        0.25
<EPS-DILUTED>                                        0.25


</TABLE>
#### Frank Cullen, Respondent, *v.*The Metropolitan Street Railway Co., Appellant.

Appeal from a judgment of the City Court of the city of New York in favor of plaintiff.

Henry A. Robinson, for appellant.

Lamb, Osborne *&*Petty, for respondent.

McCarthy, J.

We find that the record made below contains no error calling for reversal.

Judgment and order appealed from are affirmed, with costs.

Hascall, J., concurs.

Judgment and order affirmed, with costs.
#### § 150.180 May I perform fiduciary services for, or purchase fiduciary services from, another association or entity?

You may perform services related to the exercise of fiduciary powers for another association or other entity under a written agreement. You may also purchase services related to the exercise of fiduciary powers from another association or other entity under a written agreement.
**UN PUBLISHED** 

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 16** 
**- 7352** 

BRADLEY MAXWELL ,
Plaintiff

- Appellant ,

v.

HAROLD CLARKE; DAVID ROBINSON; TERRY GLENN; HENRY PONTON; LESLIE FLEMING ,
Defendants

- Appellees

.

Appeal from the United States District Court for the Western District of Virginia , at Roanoke

. Norman K. Moon , Senior District Judge. ( 7:15

- cv
- 00468

- NKM

- RSB )

Submitted : January 31, 2017 Decided: February 3, 2017

Before WILKINSON, KEENAN , and THACKER, Circuit Judges.

Affirmed by un published per curiam opinion

.

Bradley Maxwell , Appellant Pro Se. Nancy Hull Davidson, Assistant Attorney General, Richmond, Virginia, for Appellees.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM:
Bradley Maxwell appeals the district court ’ s order denying

relief on his 42 U.S.C. § 1983 (20 12 ) complaint. We have
reviewed the record and find no reversible error. Accordingly,
we affirm for the reasons stated by the district c ourt. Maxwell

v. Clarke , No. 7:15

- cv
- 00468

- NKM

- RSB (W.D

. Va. Sept. 26, 2016).
We dispense with oral argument because the facts and legal
contentions are adequately presented in the materials before

th is court and argument would not aid the decisional pro cess.

AFFIRMED
#### Charles Schurck, Respondent, *v.*Mary E. Nutter, Appellant.

Appeal from a judgment of the City Court of the city of New York, entered upon verdict and order denying new trial.

Gifford, Stearns & Hobbs (William S. Haskell, of counsel), for appellant.

Thompson *&*Maloney (J. Campbell Thompson, of counsel), for respondent.

Hascall, J.

It seems to us, from the testimony adduced upon the trial, that respondent sustained the allegations of his complaint, by the necessary weight of evidence, which enabled the jury to say that the appellant promised or agreed to pay the commission sued for, of was cognizant of effort being made in her behalf for which, if successful, she would be obliged to pay the customary rate. We also find that the question was fairly submitted below.

Judgment and order appealed from should be affirmed, with costs.

Fitzsimons, Ch. J., concurs.

Judgment and order affirmed, with costs.
EX-4.36



 Exhibit 4.36 

Amendment Agreement No. 1 to the Term Storage Contract 

No. 2010-01 dated 17-09-2010 

Between 
 Antwerp
Terminal and Processing Company N.V. 
 And 

Vitol SA 

  
 1 








 THIS AMENDMENT AGREEMENT NO. 1 is made on this 28th day of
April 2015 
 BETWEEN 
  

	 	1.	Antwerp Terminal and Processing Company N.V., now known as ATPC Terminal N.V., is a company incorporated under the laws of Belgium with a registered office at Beliweg 20, Port n° 279, B2030 Antwerp, Belgium
(“the Company”); and 

 AND 
  

	 	2.	Vitol SA, a private company limited by shares, incorporated and existing under Swiss law, having its official seat in Geneva, Switzerland and its principal place of business at Boulevard du Pont d’Arve 28,
1205 Geneva, Switzerland (“the Client”). 

 WHEREAS 
  

	 	(A)	The Company and the Client are parties to a Term Storage Contract No. 2010-01 dated 17-09-2010 in connection with gasoil storage and handling services at the Company’s terminal. 


 

	 	(B)	For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Client now wish to further amend the Contract in accordance with this Amendment Agreement No. 1.


 NOW THEREFORE it is agreed as follows: 
  

	1.	The Company and the Client agree to amend the Storage Period as set forth in Article 4 of the Term Storage Contract from 15 September 2015 to 30 June 2015. 


 

	2.	Save to the extent as amended by this Amendment Agreement No. 1, all terms and conditions of the Term Storage Contract shall remain in full force and effect. 


 

	3.	This Amendment Agreement No. 1 may be executed in counterparts. 

  

	4.	Clauses 22 and 23 of the Term Storage Contract shall apply mutatis mutandis to this Amendment Agreement No. 1 as if references therein to the Term Storage Contract were to this Amendment Agreement No. 1.


  

	5.	Capitalised terms not otherwise defined in this Amendment Agreement No. 1 shall have the same meaning as in the Term Storage Contract. 


  
 2 








 IN WITNESS WHEREOF the Client and the Company have caused this Amendment Agreement No. 1 to be executed by their
duly authorized representatives, as of the date first above written. 
  

			
	ATPC Terminal N.V.
	
	 /s/ Gert Quint

	Name:		Gert Quint
	Position:		Director
	Date:		
	Place:		
	
	Vitol S.A.
	
	 /s/ David Fransen

	Name:		David Fransen
	Position:		Managing Director
	Date:		April 29, 2015
	Place:		Geneva, Switzerland


  
 3
# C_2023105EN.01001401.xml

| 21.3.2023 | EN | Official Journal of the European Union | C 105/14 |
| --- | --- | --- | --- |

21.3.2023

EN

Official Journal of the European Union

C 105/14

---

Euro exchange rates (1)

20 March 2023

(2023/C 105/08)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,0717 |
| JPY | Japanese yen | 140,77 |
| DKK | Danish krone | 7,4450 |
| GBP | Pound sterling | 0,87560 |
| SEK | Swedish krona | 11,1564 |
| CHF | Swiss franc | 0,9928 |
| ISK | Iceland króna | 150,10 |
| NOK | Norwegian krone | 11,4210 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 23,988 |
| HUF | Hungarian forint | 399,21 |
| PLN | Polish zloty | 4,7045 |
| RON | Romanian leu | 4,9233 |
| TRY | Turkish lira | 20,3838 |
| AUD | Australian dollar | 1,5978 |
| CAD | Canadian dollar | 1,4669 |
| HKD | Hong Kong dollar | 8,4038 |
| NZD | New Zealand dollar | 1,7106 |
| SGD | Singapore dollar | 1,4354 |
| KRW | South Korean won | 1 401,82 |
| ZAR | South African rand | 19,7861 |
| CNY | Chinese yuan renminbi | 7,3739 |
| IDR | Indonesian rupiah | 16 453,38 |
| MYR | Malaysian ringgit | 4,8076 |
| PHP | Philippine peso | 58,281 |
| RUB | Russian rouble | |
| THB | Thai baht | 36,513 |
| BRL | Brazilian real | 5,6183 |
| MXN | Mexican peso | 20,3003 |
| INR | Indian rupee | 88,4900 |

Currency

Exchange rate

USD

US dollar

1,0717

JPY

Japanese yen

140,77

DKK

Danish krone

7,4450

GBP

Pound sterling

0,87560

SEK

Swedish krona

11,1564

CHF

Swiss franc

0,9928

ISK

Iceland króna

150,10

NOK

Norwegian krone

11,4210

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

23,988

HUF

Hungarian forint

399,21

PLN

Polish zloty

4,7045

RON

Romanian leu

4,9233

TRY

Turkish lira

20,3838

AUD

Australian dollar

1,5978

CAD

Canadian dollar

1,4669

HKD

Hong Kong dollar

8,4038

NZD

New Zealand dollar

1,7106

SGD

Singapore dollar

1,4354

KRW

South Korean won

1 401,82

ZAR

South African rand

19,7861

CNY

Chinese yuan renminbi

7,3739

IDR

Indonesian rupiah

16 453,38

MYR

Malaysian ringgit

4,8076

PHP

Philippine peso

58,281

RUB

Russian rouble

THB

Thai baht

36,513

BRL

Brazilian real

5,6183

MXN

Mexican peso

20,3003

INR

Indian rupee

88,4900

---

(1)  Source: reference exchange rate published by the ECB.

---
# C_2023313EN.01000301.xml

| 4.9.2023 | EN | Official Journal of the European Union | C 313/3 |
| --- | --- | --- | --- |

4.9.2023

EN

Official Journal of the European Union

C 313/3

---

Interest rate applied by the European Central Bank to its main refinancing operations (1):

4,25 % on 1 September 2023

Euro exchange rates (2)

1 September 2023

(2023/C 313/03)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,0844 |
| JPY | Japanese yen | 157,47 |
| DKK | Danish krone | 7,4528 |
| GBP | Pound sterling | 0,85538 |
| SEK | Swedish krona | 11,8960 |
| CHF | Swiss franc | 0,9574 |
| ISK | Iceland króna | 142,50 |
| NOK | Norwegian krone | 11,4860 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,118 |
| HUF | Hungarian forint | 383,73 |
| PLN | Polish zloty | 4,4685 |
| RON | Romanian leu | 4,9459 |
| TRY | Turkish lira | 28,9752 |
| AUD | Australian dollar | 1,6737 |
| CAD | Canadian dollar | 1,4656 |
| HKD | Hong Kong dollar | 8,5068 |
| NZD | New Zealand dollar | 1,8164 |
| SGD | Singapore dollar | 1,4640 |
| KRW | South Korean won | 1 428,30 |
| ZAR | South African rand | 20,2711 |
| CNY | Chinese yuan renminbi | 7,8679 |
| IDR | Indonesian rupiah | 16 526,26 |
| MYR | Malaysian ringgit | 5,0397 |
| PHP | Philippine peso | 61,312 |
| RUB | Russian rouble | |
| THB | Thai baht | 37,916 |
| BRL | Brazilian real | 5,3495 |
| MXN | Mexican peso | 18,5188 |
| INR | Indian rupee | 89,6970 |

Currency

Exchange rate

USD

US dollar

1,0844

JPY

Japanese yen

157,47

DKK

Danish krone

7,4528

GBP

Pound sterling

0,85538

SEK

Swedish krona

11,8960

CHF

Swiss franc

0,9574

ISK

Iceland króna

142,50

NOK

Norwegian krone

11,4860

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,118

HUF

Hungarian forint

383,73

PLN

Polish zloty

4,4685

RON

Romanian leu

4,9459

TRY

Turkish lira

28,9752

AUD

Australian dollar

1,6737

CAD

Canadian dollar

1,4656

HKD

Hong Kong dollar

8,5068

NZD

New Zealand dollar

1,8164

SGD

Singapore dollar

1,4640

KRW

South Korean won

1 428,30

ZAR

South African rand

20,2711

CNY

Chinese yuan renminbi

7,8679

IDR

Indonesian rupiah

16 526,26

MYR

Malaysian ringgit

5,0397

PHP

Philippine peso

61,312

RUB

Russian rouble

THB

Thai baht

37,916

BRL

Brazilian real

5,3495

MXN

Mexican peso

18,5188

INR

Indian rupee

89,6970

---

(1)  Rate applied to the most recent operation carried out before the indicated day. In the case of a variable rate tender, the interest rate is the marginal rate.

(2)  Source: reference exchange rate published by the ECB.

---
EXHIBIT
11(a)
   Year Ended
    
    
    Year Ended
    
    
    Year EndedDecember 31,
    
    
    December 31,
    
    
    December 31,2009
    
    

2008
    
    

2007Net (loss) income applicable to common stock

    
    $
    (58,403,000
    )
    
    $
    1,797,000
    
    
    $
    40,617,000Weighted average common shares outstanding

    
    
    91,730,109
    
    
    
    92,125,660
    
    
    
    96,779,009Shares issueable upon exercise of stock options

    
    
    
    
    
    
    181,180
    
    
    
    774,898Incremental shares of convertible debt

    
    
    
    
    
    
    
    
    
    
    Weighted average common shares and common
equivalents outstanding

    
    
    91,730,109
    
    
    
    92,306,840
    
    
    
    97,553,907Net (loss) income per common share basic and diluted

    
    $
    (0.64
    )
    
    $
    0.02
    
    
    $
    0.42
  Year Ended


    Year Ended
    
    
    Year EndedDecember 31,


    December 31,
    
    
    December 31,2009



2008
    
    

2007Net (loss) income applicable to common stock
    
    $
    (58,403,000
    )

    $
    1,797,000
    
    
    $
    40,617,000Income impact of assumed conversions
    
    
    2,295,455


    
    4,256,797
    
    
    
    4,496,500(Loss) income
available to common shareholders plus assumed conversion
    
    $
    (56,107,545
    )

    $
    6,053,797
    
    
    $
    45,113,500Weighted average common shares outstanding
    
    
    91,730,109


    
    92,125,660
    
    
    
    96,779,009Shares issuable upon exercise of stock options
    
    
    105,985


    
    181,180
    
    
    
    774,898Incremental shares from convertible debt
    
    
    2,474,107


    
    5,879,893
    
    
    
    5,813,730Weighted average common shares plus dilutive
potential common shares
    
    
    94,310,201


    
    98,186,733
    
    
    
    103,367,637Net (loss) income  per common share
    
    $
    (0.59
    )

    $
    0.06
    
    
    $
    0.44
Order entered May 4, 2015

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00782-CV

EBAY INC., Appellant

V.

MARY KAY INC., Appellee

On Appeal from the 101st Judicial District Court

Dallas County, Texas

Trial Court Cause No. DC-1403318

ORDER

Before the Court is appellee’s April 30, 2015 motion for leave to file a post-submission 

letter brief. We GRANT the motion. Appellee’s post-submission letter brief, which was 

tendered along with the motion, is deemed filed as of the date of this order.

/s/ CRAIG STODDART 

PRESIDING JUSTICE
<TABLE> <S> <C>

<ARTICLE>      5
<MULTIPLIER>   1
       
<S>            <C>
<PERIOD-TYPE>  9-MOS
<FISCAL-YEAR-END>   DEC-31-1998
<PERIOD-START> JAN-01-1998
<PERIOD-END>   SEP-30-1998
<CASH>         823,135
<SECURITIES>   0
<RECEIVABLES>  10,485
<ALLOWANCES>   0
<INVENTORY>         595,955
<CURRENT-ASSETS>    2,071,977
<PP&E>         505,371
<DEPRECIATION> 169,786
<TOTAL-ASSETS> 2,668,824
<CURRENT-LIABILITIES>    349,461
<BONDS>        8,175,261
<COMMON>       218,142
<PREFERRED-MANDATORY>    426,125
<PREFERRED>         0
<OTHER-SE>          (6,150,704)
<TOTAL-LIABILITY-AND-EQUITY>  2,668,824
<SALES>        203,675
<TOTAL-REVENUES>    203,675
<CGS>               555,607
<TOTAL-COSTS>  1,106,888
<OTHER-EXPENSES>    0
<LOSS-PROVISION>    0
<INTEREST-EXPENSE>  424,196
<INCOME-PRETAX>     (1,826,662)
<INCOME-TAX>   0
<INCOME-CONTINUING> (1,826,662)
<DISCONTINUED> 0
<EXTRAORDINARY>     0    
<CHANGES>      0
<NET-INCOME>   (1,826,662)    
<EPS-PRIMARY>  (0.09)    
<EPS-DILUTED>  (0.09)         
               

</TABLE>
EXHIBIT 32.1



Certification



Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and
Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.§ 1350), James M. Frincke, Interim Chief Executive Officer of Hollis-Eden Pharmaceuticals, Inc., a Delaware corporation (the Company), and
Robert W. Weber, Interim Chief Financial Officer/Chief Accounting Officer and Vice PresidentOperations of the Company, each hereby certifies that, to the best of his knowledge:



1. The Companys Annual Report on Form 10-K for the period ended December 31, 2008, to which this Certification is
attached as Exhibit 32.1 (the Annual Report) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and



2. The information contained in the Annual Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.



|                      |  |     |  |                                                                                                                                   
|--------------------- |  | --- |  | ----------------------------------------------------------------------------------------------------------------------------------
|Dated: March 30, 2009 |  | By: |  | /s/    JAMES M.
FRINCKE                                                                                                           
|                      |  |     |  | James M. Frincke Interim Chief Executive Officer (Principal Executive Officer)                                                    
|                      | 
|                      |  |    
|Dated: March 30, 2009 |  | By: |  | /s/    ROBERT W.
WEBER                                                                                                            
|                      |  |     |  | Robert W. Weber Interim Chief Financial Officer/Chief Accounting Officer/ Vice President, Operations
(Principal Financial Officer)
|                      | 
|                      | 



|* | This certification accompanies the Annual Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into
any filing of Hollis-Eden Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Annual Report), irrespective of any general incorporation
language contained in such filing.
|- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------